Evidence map›Paper›PMID 28529951›Full record

Trial reportBioMed research international2017

Immunity Enhancement in Immunocompromised Gastrointestinal Cancer Patients with Allogeneic Umbilical Cord Blood Mononuclear Cell Transfusion.

Ying Qiu, Ruidong Zhao, Mark M Yun, Xia Han, Feiyu Yun, Bingchun Liu, Erxia Zhou, Xiaohui Ouyang, Sheng Yun

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ying QiuStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Ruidong ZhaoStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Mark M YunMedical School, University College London, Gower Street, London WC1E 6BT, UK.
Xia HanStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Feiyu YunStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Bingchun LiuStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Erxia ZhouStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Xiaohui OuyangStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.
Sheng YunStem Cell Centre/Department of Oncology, Affiliated Hospital of Inner Mongolia Medical University, Huhhot 010050, China.ORCID 0000-0002-8767-9591
Inner Mongolia Medical University · CNUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overFemaleFetal BloodFlow CytometryGastrointestinal NeoplasmsHumansInterferon-gammaLeukocytes, MononuclearMaleMiddle AgedNeoplasm Recurrence, LocalTumor Necrosis Factor-alphaIFNG protein, humanInterferon-gammaTumor Necrosis Factor-alpha

Identifiers

PMID28529951
PMCPMC5424190
OpenAlexW2607963110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.